The Most Important Healthcare And Life Science Deals Of 2025
Attorneys taking stock of 2025 spoke to Law360 about the most important deals of the year, including Pfizer’s high-profile acquisition of Metsera and transactions in outpatient services and gene therapy.
Bazelon Center Dir. On Disabilities And Medicaid 'Barriers'
Law360 Healthcare Authority talks to Jennifer Mathis of the Bazelon Center for Mental Health Law about Medicaid, disability law and what states should do to stop people with impairments from being disenrolled improperly.
.jpg)
Lax Enforcement Spurs Suits Over Insurers' 'Ghost' Networks
More patients are alleging that what are known as insurers' ghost networks — directories full of unreachable providers — deny them access to mental health care. Their counsel say scarce enforcement is just one of the problems.
The Most Important Healthcare And Life Science Deals Of 2025
Attorneys taking stock of 2025 spoke to Law360 about the most important deals of the year, including Pfizer’s high-profile acquisition of Metsera and transactions in outpatient services and gene therapy.
Bazelon Center Dir. On Disabilities And Medicaid 'Barriers'
Law360 Healthcare Authority talks to Jennifer Mathis of the Bazelon Center for Mental Health Law about Medicaid, disability law and what states should do to stop people with impairments from being disenrolled improperly.
Lax Enforcement Spurs Suits Over Insurers' 'Ghost' Networks
More patients are alleging that what are known as insurers' ghost networks — directories full of unreachable providers — deny them access to mental health care. Their counsel say scarce enforcement is just one of the problems.
Expert Analysis
As 2025 draws to a close, psychedelic drug development stands at an inflection point, experiencing unprecedented m... (more story)
As 2025 nears its end, claims professionals should be aware of trends in state legislation addressing artificial i... (more story)
False Claims Act enforcement trends and legislative developments from this year signal intensifying state and fede... (more story)
Deals & Corporate Governance More
Medical device provider AdaptHealth Corp. has agreed to pay $35 million to settle a lawsuit accusing it of deceiving shareholders about its revenue projections as it "routinely engaged in improper and unethica... (more story)
A sweep of settlements in major lawsuits punctuated the second half of the year in North Carolina, from a record-breaking wrongful death deal to an eleventh-hour resolution in a lending fight over a biogas dev... (more story)
A Quantum Biopharma investor has filed a proposed class action against several major Canadian banks, accusing them of running a spoofing scheme for years that artificially drove down Quantum's stock price — fl... (more story)
In this week's Taxation With Representation, Trump Media and Technology Group merges with fusion power company TAE Technologies, pharmaceutical company Cencora boosts its stake in cancer care company OneOncolo... (more story)
Eye disease treatment developer Clearside Biomedical on Friday got permission from a Delaware bankruptcy judge for a January auction of its assets after saying it had resolved objections from shareholders and ... (more story)
BioMarin Pharmaceutical Inc. has agreed to acquire Amicus Therapeutics for $4.8 billion, in a deal bolstered by Amicus' settlement of patent litigation that secures U.S. exclusivity for its Galafold drug until... (more story)
Digital Health & Technology More
A Pittsburgh law firm that handles medical malpractice and insurance litigation faces a proposed class action complaint alleging that it failed to protect the private health and personal data of patients whose... (more story)
The maker of an in vitro fertilization incubator system has filed a breach of contract lawsuit in Colorado federal court, claiming an artificial intelligence-based fertility company owes it nearly $900,000 for... (more story)
The U.S. International Trade Commission has had a busy week in intellectual property, determining a series of toy gun imports don't infringe Spin Master patents licensed to Hasbro, instituting reviews requeste... (more story)
A Pennsylvania federal judge has dismissed a proposed data breach class action against Thomas Jefferson University Hospitals Inc. over the named plaintiffs purported inability to serve as leaders of the suit, ... (more story)
Texas Attorney General Ken Paxton hit Epic Systems Corp. with an antitrust suit in state court on Wednesday alleging the company is illegally seeking to monopolize markets for electronic health records software.
An Illinois state appeals court affirmed the dismissal of a man's suit claiming two State Farm life insurers violated Illinois' genetic information privacy law, finding a section barring the use of genetic pro... (more story)
Policy & Compliance More
A Washington, D.C., federal judge on Tuesday refused to block the Trump administration's new $100,000 H-1B visa fee, ruling in the U.S. Chamber of Commerce's lawsuit challenging the fee that President Donald T... (more story)
Philadelphia on Tuesday sued drug manufacturers Eli Lilly, Novo Nordisk and Sanofi, along with several pharmacy benefit managers, joining multidistrict litigation in New Jersey federal court accusing the compa... (more story)
The Trump administration finalized changes to the H-1B lottery Tuesday, unveiling a final rule it said will favor higher-paid and higher-skilled positions and tamp down on employers exploiting the program to h... (more story)
Tela Bio Inc. slapped Becton Dickinson and Co. and its subsidiaries with an antitrust lawsuit Friday in Pennsylvania federal court accusing the medical tech giant of abusing its dominant position in the hernia... (more story)
The U.S. Department of Education will not be allowed to cut more than $1 billion in mental health grants for schools after a Washington federal judge ruled that the agency acted illegally by citing new, undisc... (more story)
A Massachusetts federal judge spared AstraZeneca unit Alexion on Friday from half of a nonprofit insurer's proposed class action, finding the plaintiff too far removed from anticompetitive patent fraud that al... (more story)